Safety and Immunogenicity of XBB.1.5-Containing mRNA Vaccines
收藏官方服务：
资源简介：
Safety and Immunogenicity of XBB.1.5-Containing mRNA Vaccines
应用场景：
创建时间：
2023-09-07
相关数据集
MHC-II binding results for the identified four peptide segments.
Results of the peptide-a, b, c and d submitted to the IEDB T-cell MHC-II binding prediction server are tabulated here. For each peptide the server generates two overlapping peptides; the peptides for
NIAID Data Ecosystem60
Carrier Properties of a Protein Derived from Outer Membrane Protein A of Klebsiella pneumoniae
We have recently cloned a new protein, recombinant P40 (rP40). When tested in vivo after conjugation to a B-cell epitope, rP40 induces an important antibody response without the need for adjuvant. To
PubMed Central20
Dataset from A Dose-range Study to Assess the Safety and Immunogenicity of a Novel HPV Vaccine When Administered Intramuscularly According to a 3-dose Schedule (0,1,6-month) in Healthy Adult Females (18-25 Years of Age)
Human Papilloma viruses (HPV) are viruses that cause infections of the skin and genitals in men and women. Several types of HPV infection are transmitted by sexual activity and, in women, can infect t
NIAID Data Ecosystem10
The sequences of primers used in the study.
The current COVID-19 mRNA vaccines were developed and applied for pandemic-emergent conditions. These vaccines use a small piece of the virus’s genetic material (mRNA) to stimulate an immune response
Figshare2024-10-10 更新30
Investigating cellular transcriptomic alterations caused by VEEV replicase and SARS-CoV-2 mRNA co-transfection
The viral RNA-dependent RNA polymerase (replicase) from Venezuelan equine encephalitis virus constitutes a vital component of the bipartite trans-amplifying mRNA vaccine. In this vaccine strategy aime
NIAID Data Ecosystem10
